Type 1 Diabetes
Hybrid closed-loop system improves HbA1c for adults missing meal boluses
SAN DIEGO — Use of an automated insulin delivery system can lower HbA1c and improve time in range without increasing time below range for people with type 1 diabetes who tend to miss meal boluses, according to a speaker.
Recombinant human glutamic acid decarboxylase may preserve C-peptide in type 1 diabetes
Recombinant human glutamic acid decarboxylase formulated with aluminum hydroxide may preserve C-peptide and improve HbA1c for people with type 1 diabetes carrying a specific genotype, according to findings from a meta-analysis.
FDA places hold on trial of novel cell therapy for type 1 diabetes
The FDA has halted a clinical trial for an investigational stem cell-derived therapy for people with type 1 diabetes, according to an industry press release.
Extended-wear insulin infusion set lasts 7 days for most wearers, with few adverse events
A novel extended-wear insulin infusion set was usable for up to 7 days for most adults with type 1 diabetes, with no change in glycemic control and few adverse events, according to findings published in Diabetes Technology & Therapeutics.
Toolkit educates young adults with type 1 diabetes on navigating financial barriers
Young adults with type 1 diabetes said they gained knowledge about financial issues and health insurance after participating in a novel online educational program, according to study findings.
Increased mortality risk for men with type 1 diabetes, regardless of cognitive ability
Swedish men diagnosed with type 1 diabetes in youth had higher all-cause and cardiovascular mortality risks compared with those without diabetes, and cognitive ability did not influence the associations, according to study data.
Comorbidities in type 1 diabetes more common with family history of the disease
People with type 1 diabetes who have a family history of the disease are more likely to have related comorbidities, compared with those without that family history, according to data from the T1D Exchange Clinic Registry.
DKA more common for Black vs. white people with type 1 diabetes before, during pandemic
Black people with type 1 diabetes were more likely to have a diabetic ketoacidosis event before the COVID-19 pandemic in 2019 than other racial-ethnic groups, and that disparity persisted in 2020, according to study findings.
Addition of empagliflozin improves daytime glucose in type 1 diabetes
Empagliflozin added to automated insulin delivery or predictive low-glucose suspend systems significantly benefited daytime glucose levels for people with type 1 diabetes, with no extra hypoglycemia risk, according to new data.
Symptomatic diabetic autonomic neuropathy common in adults with type 1 diabetes
About one in five adults with type 1 diabetes reports having symptomatic diabetic autonomic neuropathy, according to study findings published in the Journal of Diabetes and Its Complications.